In addition to acting through the p38 pathway, GLP-1RAs also promote the increase of PKA levels via the cAMP-dependent pathway, which in turn prevents the phosphorylation of epidermal growth factor receptor (EGFR) and activator of transcription 3 (STAT3), resulting in the inactivation of the EGFR-STAT3 signaling pathway in tumor cells and subsequently downregulating several downstream effector genes such as myelocytomatosis oncogene (c-Myc), survivin, cyclin D1, Bcl-xl, and Bcl-2, thereby inducing apoptosis in tumor cells in a dose-dependent manner [70, 73]
Petrelintide is a long-acting amylin analog, and Roche secured global rights
What GLP-1 Medications Actually Do GLP-1 medications mimic naturally occurring hormones involved in regulating: Appetite Satiety (feeling full) Blood sugar regulation Gastric emptying Metabolic function By slowing how quickly food leaves the stomach and supporting appetite regulation, these medications may help individuals feel fuller for longer periods and reduce excessive hunger signals
If youre eating fewer calories because of GLP-1 treatment, theres a good chance youre eating less iron, too
[PubMed] Compound 2: KPV Research Findings Cellular Macrophage activation studies